A Look at the Latest Plan Availability and Premium Data for the Medicare Part D Stand-Alone Prescription Drug Plan Market for 2026

Medicare Open Enrollment begins October 15.

View in browser NEW & NOTEWORTHY KFF Examines Plan Availability and Premium Data for the Medicare Part D Stand-Alone Prescription Drug Plan Market for 2026 As this year's Medicare open enrollment period approaches, a new KFF analysis takes a preliminary look at trends in premiums and plan offerings in the market for Part D stand-alone prescription drug plans for 2026, based on data from the Centers for Medicare and Medicaid Services (CMS).   A separate new KFF analysis provides an overview of the current Medicare Part D program, plan availability, enrollment, and spending and financing, based on data from CMS and other sources. It also provides an overview of changes to the Part D benefit based on provisions in the Inflation Reduction Act.   In 2025, 54.8 million of the 68.8 million Medicare beneficiaries in total are enrolled in Medicare Part D plans. Medicare's annual open enrollment period runs from Oct. 15 through Dec. 7. CONTACT:   Chris Lee | 202.654.1403 | ChrisL@kff.org    KFF should be cited as a nonprofit health policy research, polling, and news organization.  Did someone forward this to you? Sign up for emails from KFF. This email was sent to albarkahslamet.ssss@blogger.com. Update your email preferences to choose the types of emails you receive. Or, permanently unsubscribe from all future emails. Need assistance? Email subscriptions@kff.org; do not reply to this email. The independent source for health policy research, polling, and news. KFF, 185 Berry Street, Suite 2000, San Francisco, CA 94107